PCT · PureCycle Technologies
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $2.79
Note written ·
Price against the kill line
38.9% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $2.79, on record since 10 November 2026. The shares are down 76.4% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $2.79, the close before the results of 4 November 2026 (4 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Materials
Quarter to 30 September 2026, filed 4 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 2.3
- Revenue, change on a year (%)
- −3.3
- Operating margin (%)
- −1594.7
- Free cash flow, four quarters ($M)
- −209
- Free-cash-flow yield (%)
- −61.0
All filed numbers
What PureCycle Technologies reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Operating margin (%) |
|---|---|---|---|
| first filed | 2.3 | −3.3 | −1594.7 |
| first filed | 4.5 | +173.5 | −916.1 |
| first filed | 4.1 | +161.2 | −1012.7 |
| first filed | 2.7 | — | −2196.1 |
| first filed | 2.4 | — | −1602.2 |
| first filed | 1.6 | — | −2763.5 |
| Pre-tax income ($M) | Not reported |
| Net income ($M) four quarters: −188 | 6.9 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | +9.0 |
| Operating cash flow ($M) | −154 |
| Capital spending ($M) | 55.4 |
| Free cash flow ($M) | −209 |
| Cash and short-term investments ($M) | 180 |
| Debt ($M) | Not available |
| Net cash, cash less debt ($M) | Not available |
| Deferred revenue ($M) 0.0% on a year | 5.0 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 4.1 |
| Inventory ($M) | 20.2 |
| Shareholders' equity ($M) | 18.5 |
| Market value ($M) | 343 |
| Enterprise value, market value plus net debt ($M) | Not available |
| Enterprise value to sales (×) | Not available |
| Enterprise value to operating income (×) | Not available |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 18.5 |
| Free-cash-flow yield (%) | −61.0 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 32.5% of shares outstanding sold short, 10.0 days of average trading to cover, +11.4% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $99K | $0 |
| 12 monthsfrom | $99Kand 1 trade without a stated price | $0 |
The thesis
PureCycle Technologies' operating case failed its own test: third-quarter output of 5.2 million pounds, reported on 4 November 2026, came in below the 8.4-million-pound first-quarter record. The shares closed at $2.06 on 9 November 2026, down 71.3% over three months, and the next evidence is whether fourth-quarter output and commercial volume rise from this level.
The narrative is dead as a squeeze story and unproven as an operating story: the shares sit 85.2% below the 52-week high of $13.95, and the third-quarter report gave no new Ironton breakeven date in its release text. The shares closed at $2.98 on 27 October 2026, below the $2.70 level that note set, and third-quarter output finished under 8.4 million pounds.
Third-quarter revenue was $2.3 million against $4.5 million in the second quarter, according to the company's 4 November 2026 release. Benzinga's headline put the miss at $2.349 million against an $8.278 million estimate. Liquidity was $193 million at 30 September 2026, down from $236.9 million at 30 June 2026, plus an undrawn $200 million revolver.
Bullish and bearish views on PureCycle Technologies, Inc.
The bull case on PureCycle Technologies, Inc. (PCT), in brief: output turned up from the second quarter. The bear case: output is below last year and the record.
Bull case
- Output turned up from the second quarter. PureFive production was 5.2 million pounds in the third quarter against 4.5 million in the second, per the company's 4 November 2026 release. Management said two reliability issues that limited output and quality were resolved and that production is in line with current commercial demand.
- Consumer products reached shelves. The release states Procter & Gamble products, including Tide caps, are on shelves, with first Tide deliveries in October.
- Feedstock and maturity are covered. The company signed a three-year agreement with WM for up to 25 million pounds a year, starting in November, according to a third-party review of the report. The $200 million revolver matures on 30 September 2028, per the company's 8-K of 28 August 2026.
- Liquidity is still large against near-term spending. The company guided fourth-quarter project spend of about $4 million and debt service of about $9.4 million; cash was $109 million and marketable securities $71.4 million at 30 September 2026.
- Insider and leadership change. Director Fernando Musa bought 15,479 shares at an average $6.38 on 4 September 2026, per MarketBeat insider data. The company named him Executive Chairman from 3 November 2026 through 31 December 2027, with Dan Coombs staying on the board and Dustin Olson remaining chief executive.
Bear case
- Output is below last year and the record. Third-quarter production of 5.2 million pounds compares with 7.3 million in the third quarter of 2025 and 8.4 million in the first quarter of 2026, per the company.
- Revenue misses are repeating. Third-quarter revenue of $2.349 million missed an $8.278 million estimate, per Benzinga's 4 November 2026 headline. Second-quarter revenue of $4.51 million had also missed the $6.11 million estimate, per MarketBeat.
- Food-contact volume moved out. A third-party summary of the report says New Jersey's extension of its food-contact exemption pushed about 15 programs, roughly 50 million pounds of expected annual volume at full ramp, out of the fourth quarter.
- Losses continue beneath a flattering headline. The company reported net income of $6.9 million only because of a $58.6 million non-cash gain on warrant fair value. The operating loss was $37.5 million and adjusted EBITDA (earnings before interest, tax, depreciation and amortisation, adjusted) was a loss of $28.0 million.
- Thailand is unfunded. The release puts the project near $250 million, with more than $85 million invested and financing terms still under negotiation. Groundbreaking waits on financial close timing.
- Analysts and lawyers are reacting. Cantor Fitzgerald kept its overweight rating and lowered its target to $8 on 5 November 2026, from $12 on 7 August 2026, per news headlines. A Levi & Korsinsky investigation notice was published the same day.
Price setup
The shares closed at $2.06 on 9 November 2026, against $2.98 on 27 October 2026. The 14-day Relative Strength Index (a momentum gauge where readings under 30 mean heavy selling) was 35.8. MarketBeat put the 50-day moving average at $5.90 and the 200-day at $7.39 on 13 October 2026, and both sit far above the close.
Crowding evidence is thinner than a month ago. The report that drew heavy attention has passed, so no earnings date is imminent. The latest short-interest reading in hand is 55,536,978 shares at the 31 August 2026 settlement date, published 10 September 2026, and it predates the collapse; a newer reading has not been verified.
Financing terms remain far above the market. The 4.75% convertible notes due 1 July 2032 convert near $11.08, and the warrants strike at $11.50 and expire 17 March 2027. A third-party review of the report puts potential warrant proceeds near $272 million, which depends on a price more than five times the last close.
Catalysts ahead
- ~24 November 2026 (est.): Short-interest publication for the mid-November settlement date. Shows whether bearish positioning changed after the third-quarter report; the last reading in hand is from 31 August 2026.
- 30 November 2026: WM feedstock supply begins under the three-year agreement for up to 25 million pounds a year. Feedstock supply bears on whether Ironton can lift output above 5.2 million pounds a quarter.
- 31 December 2026: End of fourth quarter; the company guided about $9.4 million of debt service and about $4 million of project spend. Sets the cash drain before the fourth-quarter report that will give 2027 project spend.
What would change the view
A daily close above $2.79, the close before the results of 4 November 2026 (4 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
What it trades with
PureCycle trades on its own operating results and on short-interest and momentum flows. It has no AI exposure and no current theme cluster. Its financing terms put it closer to other pre-profit industrial-technology companies funded by convertible debt than to chemical or packaging producers.
The evidence, claim by claim (8)
- Third-quarter 2026 PureFive production was 5.2 million pounds, against 4.5 million in Q2 2026 and 7.3 million in Q3 2025. PureCycle Q3 2026 results release, 4 November 2026 · as of
- Third-quarter revenue was $2.3 million, adjusted EBITDA was a loss of $28.0 million and operating loss was $37.5 million; net income of $6.9 million included a $58.6 million non-cash warrant gain. PureCycle Q3 2026 results release · as of
- Liquidity was $193 million: $109 million cash, $71.4 million marketable securities and $12.6 million restricted cash, plus an undrawn $200 million revolver maturing 30 September 2028. PureCycle Q3 2026 results release · as of
- Q3 sales of $2.349 million missed an $8.278 million estimate. Benzinga headline, 4 November 2026 · as of
- Fernando Musa became Executive Chairman effective 3 November 2026 through 31 December 2027; Dan Coombs stepped down as chairman and stays on the board. PureCycle announcement, 4 November 2026 · as of
- Cantor Fitzgerald maintained overweight and lowered its price target to $8. Benzinga news headline, 5 November 2026 · as of
- Thailand project cost is about $250 million with more than $85 million invested; financing terms are under negotiation and the construction permit was issued in September. PureCycle Q3 2026 results release · as of
- Director Fernando Musa bought 15,479 shares at an average $6.38, about $98,756 in total. MarketBeat insider data · as of
Sources
- PureCycle Technologies Reports Third Quarter 2026 Results · finviz.com
- PureCycle misses badly as New Jersey delay and plant problems push Ironton breakeven out of 2026 · finviz.com
- PureCycle Technologies Q3 2026 results: branded ramps, Ironton output up, Thailand permit · chemxplore.com
- PureCycle Q3 Earnings: Addressing Operational Bottlenecks Amidst $28 Million EBITDA Loss · panabee.com